소세포 폐암에서 CAV 및 EP 복합화학요법의 교대 치료 성적
Alternating Non-Cross-Resistant Chemotherapy with CAV(Cyclophosphamide, Adriamycin, Vincristine) and EP(Etoposide, Cisplatin) in Small Cell
대한암학회지 1992년 24권 4호 p.570 ~ 576
손창학, 이봉춘, 신형규, 조기정,
소속 상세정보
손창학 ( )
인제대학교 의과대학 부속병원
이봉춘 ( )
인제대학교 의과대학 부속병원
신형규 ( )
인제대학교 의과대학 부속병원
조기정 ( )
인제대학교 의과대학 부속병원
KMID : 0360319920240040570
Abstract
Fifty-three patients with small cell lung cancer were treated with chemotherapy consisting of cyclophosphamide, adriamycin, and vincristine(CAV) alternating with etoposide and cisplatin(EP). Thoracic radiotherapy was administered to the patients
with
limited stage disease. Prophylactic cranial irradiation with 30 Gy was applied to all complete responders.
Overall response rate was 66% with 32% of complete response. The response rate was 78% (CR 41%, PR 37%) in the patients with limited state disease, and 54%(CR 23%, PR 31%) in those with extensive stage disease. Patients with good performance
score(ECOG
0-1) showed higher response rate significantly(p=0.003).
Overall median survival was 8 months(2-37+). And the median survival in patients with CR, PR, and no response(SD and PD) were 12, 7.5,and 4 months, respectively(p<0.01).
These results suggest that alternating chemotherapy with CAV and EP may be useful as a treatment strategy in small cell lung cancer, but deserves more intensive randomized trials.
키워드
원문 및 링크아웃 정보
등재저널 정보